Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.
2005; National Institutes of Health; Volume: 11; Issue: 4 Linguagem: Inglês
Autores
Andrew J. Karter, Howard H. Moffet, Jennifer Y. Liu, Melissa M. Parker, Ameena T. Ahmed, Assiamira Ferrara, Joe V. Selby,
Tópico(s)Diabetes, Cardiovascular Risks, and Lipoproteins
ResumoTo compare the effectiveness of antihyperglycemic therapies in type 2 diabetic patients with poor glycemic control (baseline glycosylated hemoglobin [HbA1C] > 8%).
Referência(s)